Lumentum Holdings Inc. — Form 10-Q Summary
Period clarification: The request metadata says “2021 Q3,” but the filing is for the fiscal quarter ended April 2, 2022 (Q3 FY2022), with comparisons to the quarter ended April 3, 2021. The current quarter was 13 weeks; the prior-year quarter was 14 weeks.
Business context
Lumentum supplies optical and photonic products through its Optical Communications (OpComms) and Commercial Lasers segments. OpComms serves telecom, datacom, consumer and industrial markets; Lasers serves manufacturing, inspection and life-science applications.
Key financial metrics
| Metric | Q3 FY2022 | Q3 FY2021 | Nine months FY2022 | Nine months FY2021 |
|---|---|---|---|---|
| Revenue | $395.4 million | $419.5 million | $1,290.5 million | $1,350.7 million |
| Gross profit / margin | $167.2 million / 42.3% | $185.0 million / 44.1% | $606.9 million / 47.0% | $620.3 million / 45.9% |
| Operating income | $46.8 million | $266.9 million | $247.9 million | $481.2 million |
| Net income | $26.0 million | $225.5 million | $164.2 million | $375.8 million |
| Diluted EPS | $0.35 | $2.85 | $2.19 | $4.78 |
| Operating cash flow | Not separately stated in the filing excerpt | Not separately stated in the filing excerpt | $345.0 million | $614.5 million |
- Segment revenue, quarter: OpComms $344.2 million, down 11.3%; Lasers $51.2 million, up 62.0%. Nine-month revenue was down 9.3% for OpComms and up 67.7% for Lasers.
- Liquidity at April 2, 2022: Cash and cash equivalents were $1,130.3 million and short-term investments were $1,433.8 million, totaling $2,564.1 million. Current assets were $3,100.6 million and current liabilities $660.7 million.
- Debt: Convertible notes had $2,361.0 million total principal outstanding: $450.0 million due 2024, $1,050.0 million due 2026 and $861.0 million due 2028. Carrying value was $1,853.7 million. The 2024 Notes’ $406.1 million carrying amount was classified as current because holders could convert.
- Cash flows, nine months: Investing activities used $369.0 million; financing activities provided $380.0 million. Capital expenditures were $62.6 million. Cash increased $356.0 million from fiscal-year start.
Material changes versus the prior comparable period
- Quarterly revenue fell 5.7%; OpComms weakness outweighed growth in Lasers. Management cited component shortages and delayed 5G deployments for telecom/datacom, and lower average selling prices from smaller chip designs in consumer/industrial products.
- Quarterly gross margin declined 1.8 percentage points, to 42.3%, reflecting product mix and lower 3D-sensing sales, $5.8 million of broker component procurement charges, and a temporary China factory closure. Nine-month gross margin rose 1.1 points, mainly on improved Lasers utilization and lower excess-inventory charges than the prior year.
- Net income comparisons are heavily affected by the prior-year Coherent merger termination gain: the 2021 comparison included a net $207.5 million benefit (a $217.6 million fee less related costs). The prior quarter also had one more week.
- Nine-month operating cash flow declined to $345.0 million from $614.5 million, including lower net income and working-capital cash uses, notably accounts receivable and inventory increases.
- In March 2022, Lumentum issued $861.0 million of 0.50% convertible notes due 2028 and received $854.8 million net proceeds. It repurchased $200.0 million of shares alongside the issuance and repurchased another $245.5 million under its buyback program during the nine-month period.
Outlook, management commentary and risks
- Management expects component supply constraints to remain a challenge at least through Q2 FY2023. Higher procurement costs have increased inventory and may weigh on near-term gross margin. The filing provides no numerical revenue or earnings guidance.
- Management expects R&D investment to increase in absolute dollars in future quarters. It believes long-term demand drivers include growth in optical networks and data centers, industrial laser applications, and developing 3D-sensing and LiDAR markets.
- Lumentum expects to complete its approximately $918 million cash acquisition of NeoPhotonics in the second half of calendar 2022, subject to remaining customary conditions, including required Chinese regulatory approval. Lumentum had funded a $30 million loan to NeoPhotonics; up to $50 million was authorized. The merger agreement provides for potential termination fees, including up to $91.8 million payable by Lumentum in specified circumstances.
- Principal risks include COVID-related disruptions, semiconductor and other supply constraints, dependence on concentrated customers and suppliers, export controls and trade restrictions, competitive pricing, foreign-exchange volatility, and acquisition execution and integration. Two customers together represented 38% of quarterly revenue and 43% of nine-month revenue.
- Management said it believes cash, cash equivalents and operating cash flow will meet liquidity and capital-spending needs for at least 12 months. The filing also identifies cash requirements from the NeoPhotonics transaction, note conversions or repayments, buybacks, capital investment and taxes.
- Other notable matters: available-for-sale investments had $11.4 million of unrealized losses, recorded outside earnings; management said it did not intend or expect to be required to sell them before recovery. The Karri/Oclaro merger litigation remained in discovery; management did not expect ordinary-course claims, individually or in aggregate, to have a material adverse effect.
Important facts for investors to verify
- Whether component availability, China factory operations and procurement costs improve as management anticipates, and the resulting effect on revenue and margins.
- Whether OpComms demand, 5G deployment timing and 3D-sensing product mix recover, and whether Lasers growth is sustained.
- Completion timing and Chinese regulatory clearance for the NeoPhotonics acquisition, total transaction funding, and integration costs and benefits.
- Cash requirements and potential dilution or cash settlement related to the convertible notes, particularly the 2024 Notes’ conversion status, alongside the expanded buyback authorization.
- Customer and supplier concentration, purchase commitments of $345.6 million, and the effect of export restrictions, trade policy and geopolitical developments on demand and supply.